CareDx (CDNA)

• Market cap: $905M
• 1 day: -0.84%
• 5 days: 4.87%
• 1 month: -0.39%
• 3 months: -6.51%
• 6 months: 20.45%
• Year to date: -7.68%
• 1 year: -0.28%
• 5 years: -75.33%
• 10 years: 236.57%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Employees: 765